Subscribe To
Aravive Announces Poster Presentation on Batiraxcept at 2023 ASCO Annual Meeting
HOUSTON, April 26, 2023 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced the presentation of a poster featuring batiraxcept data in clear cell renal cell carcinoma at the upcoming American Society of Clinical Oncology (ASCO) 2023 Annual Meeting, being held June […] The post Aravive Announces Poster Presentation on Batiraxcept at 2023 ASCO Annual Meeting appeared fir...
Read More
Posted: Apr 26 2023, 21:00
Author Name: forextv
Views: 081996